RLS-0071 Moderated Elevated Myeloperoxidase Level and Activity in an Asymptomatic Subject in Clinical Trial RLS-0071-101

26 May 2023: Articles

Unknown etiology, Educational Purpose (only if useful for a systematic review or synthesis)

Jessica M. Goss ^B* , Pamela Hair ^A , Parvathi S. Kumar ^A , Ulrich Thienel ^A , Kenji Cunnion ^A , Alexander Ellis ^A

DOI: 10.12659/AJCR.939803

Am J Case Rep 2023; 24:e939803

Table 1. Subject 1504 abnormal biochemistry and urinalysis results.

Category	Test (unit)	Visit	Result (flag)	Clinical significance	Normal reference range
General biochemistry	Protein (g/L)	Screening	71		63–80
		Day 2	62 (L)	NCS	63–80
		Day 4	58 (L)	NCS	63–80
		Day 6	64		63–80
Urinalysis	Ketones (mmol/L)	Screening	Negative		Negative
		Day 1	Trace (A)	NCS	Negative
		Day 2	Trace (A)	NCS	Negative
		Day 4	Negative		Negative
	Occult blood	Screening	Moderate (A)	NCS	Negative
		Day 2	Trace (A)	NCS	Negative
		Day 4	Negative		Negative
	Protein-urines (g/L)	Screening	Trace (A)	NCS	Negative
	Protein-urines (g/L)	Day 4	Negative		Negative
NCS – not clinically significant; A – abnormal; L – low.